Pages that link to "Q28299153"
Jump to navigation
Jump to search
The following pages link to The protein C anticoagulant system: inherited defects as basis for venous thrombosis (Q28299153):
Displaying 50 items.
- ProCMD: a database and 3D web resource for protein C mutants (Q21284212) (← links)
- Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice (Q24564490) (← links)
- A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state (Q24564642) (← links)
- New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom (Q33350605) (← links)
- Synthetic and recombinant antithrombin drugs (Q33367033) (← links)
- Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms (Q33611607) (← links)
- Thrombophilia: disorders predisposing to venous thromboembolism (Q33636714) (← links)
- Vitamin K-dependent proteins (Q33834141) (← links)
- High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. (Q33835022) (← links)
- Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer (Q33965106) (← links)
- Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms (Q34086042) (← links)
- Genetic aspects of venous thrombosis (Q34217882) (← links)
- The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V (Q34472410) (← links)
- Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects (Q35081834) (← links)
- Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states (Q35081838) (← links)
- Molecular recognition in the protein C anticoagulant pathway (Q35181632) (← links)
- Anaesthetic significance and management of a child with neonatal purpura fulminans. (Q36182088) (← links)
- Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C (Q37368145) (← links)
- Cerebral venous sinus thrombosis risk factors (Q37453642) (← links)
- Down-regulation of the clotting cascade by the protein C pathway (Q37701081) (← links)
- The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients (Q37702845) (← links)
- Lack of association between factor V Leiden and sepsis: a meta-analysis (Q38117275) (← links)
- Localization of a hydrophobic binding site for anticoagulant protein S on the beta -chain of complement regulator C4b-binding protein. (Q38307279) (← links)
- Blood coagulation and oral contraceptives. A critical review (Q38336893) (← links)
- Frequent association of thrombophilia in cerebral venous sinus thrombosis. (Q39404155) (← links)
- Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients (Q40175581) (← links)
- Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain (Q40802639) (← links)
- Hormone replacement therapy and hemostasis: principles of a complex interaction (Q41141603) (← links)
- Antithrombotic and fibrinolytic factors. A review (Q41157164) (← links)
- Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis (Q41197517) (← links)
- Endothelial Protein C Receptor Gene Variants and Risk of Thrombosis (Q41247554) (← links)
- Inherited thrombophilia and pregnancy (Q41743292) (← links)
- sEPCR Levels in Chronic Myeloproliferative Diseases and Their Association with Thromboembolic Events: A Case-Control Study (Q42107801) (← links)
- What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease? (Q42162475) (← links)
- Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis (Q42538550) (← links)
- The association of protein S Tokushima-K196E with a risk of deep vein thrombosis (Q42919824) (← links)
- The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities. (Q42945396) (← links)
- Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. (Q44563073) (← links)
- Identification of protein C epitopes altered during its nanoencapsulation (Q45827359) (← links)
- Association of anticardiolipin antibody and C677T in methylenetetrahydrofolate reductase mutation in women with recurrent spontaneous abortions: a new path to thrombophilia? (Q46431011) (← links)
- Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia. (Q47419189) (← links)
- Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders (Q47771140) (← links)
- No Correlation between Activated Protein C Resistance and Free Flap Failures in 100 Consecutive Patients (Q47983243) (← links)
- The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. (Q50866405) (← links)
- Stimulation of Sky tyrosine phosphorylation by bovine protein S--domains involved in the receptor-ligand interaction. (Q50948456) (← links)
- R147W in PROC Gene Is a Risk Factor of Thromboembolism in Thai Children. (Q50997832) (← links)
- Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function (Q51061438) (← links)
- A young patient with multiple arterial occlusions (Q51569420) (← links)
- Morphologic and biochemical features affecting the antithrombotic properties of the inferior vena cava of rabbit pups and adult rabbits. (Q52190808) (← links)
- Cardiopulmonary bypass and activation of antithrombotic plasma protein C. (Q54080510) (← links)